Molecular neuroimaging: from conventional to emerging techniques.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Radiology

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/RADIOL.2451060731PMID 17885179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

  2006cited by this paper
• Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.

  2006cited by this paper
• DifferentialDiagnosis of Alzheimer's Disease with PET

  2006cited by this paper
• Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors.

  2005cited by this paper
• Techniques to assess the proliferative potential of brain tumors

  2005cited by this paper
• Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS

  2005cited by this paper
• PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease

  2005cited by this paper
• Near-Infrared Fluorescent Imaging of Cerebral Thrombi and Blood–Brain Barrier Disruption in a Mouse Model of Cerebral Venous Sinus Thrombosis

  2005cited by this paper
• Resolution, sensitivity and precision with autoradiography and small animal positron emission tomography: implications for functional brain imaging in animal research.

  2005cited by this paper
• Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors.

  2005cited by this paper
• Detection threshold of single SPIO‐labeled cells with FIESTA

  2005cited by this paper
• The role of radiotracer imaging in Parkinson disease.

  2005cited by this paper
• Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

  2005cited by this paper
• Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

  2005cited by this paper
• Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism

  2005cited by this paper
• Small animal imaging in drug development.

  2005cited by this paper
• Limits of detection of SPIO at 3.0 T using T2* relaxometry

  2005cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005cited by this paper
• PET in seizure disorders.

  2005cited by this paper
• Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET

  2005cited by this paper
• [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors

  2005cited by this paper
• Applications of mouse glioma models in preclinical trials.

  2005cited by this paper
• Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

  2005cited by this paper
• Screening Cascade and Development of Potential Positron Emission Tomography Radiotracers for mGluR5: In vitro and In vivo Characterization

  2005cited by this paper
• Preclinical Alzheimer's disease: diagnosis and prediction of progression.

  2005cited by this paper
• The role of PET imaging in the management of patients with central nervous system disorders.

  2005cited by this paper
• Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography.

  2005cited by this paper
• PET imaging for differentiating recurrent brain tumor from radiation necrosis.

  2005cited by this paper
• In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain

  2005cited by this paper
• Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

  2005cited by this paper
• Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

  2005cited by this paper
• Reporter mice and drug discovery and development

  2005cited by this paper
• Cellular MR Imaging

  2005cited by this paper
• The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.

  2005cited by this paper
• Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease

  2005cited by this paper
• The involvement of glutamate in the pathophysiology of depression.

  2005cited by this paper
• Instant MR labeling of stem cells using magnetoelectroporation

  2005cited by this paper
• In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.

  2005cited by this paper
• The interaction of amyloid-beta with ApoE.

  2005cited by this paper
• Suppression of lipid artifacts in amide proton transfer imaging

  2005cited by this paper
• Advances in imaging mouse tumour models in vivo

  2005cited by this paper
• [18F]FDOPA PET and clinical features in parkinsonism due to manganism

  2005cited by this paper
• Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.

  2005cited by this paper
• Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

  2005cited by this paper
• 1.5 T: spectroscopy-supported brain biopsy.

  2005cited by this paper
• PAMAM dendrimer based macromolecules as improved contrast agents.

  2005cited by this paper
• Optical and MRI multifunctional nanoprobe for targeting gliomas.

  2005cited by this paper
• GABA and glutamate systems as therapeutic targets in depression and mood disorders

  2005cited by this paper
• Drug development and PET-diagnostics for Alzheimer's disease.

  2005cited by this paper
• Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression

  2005cited by this paper
• Imaging in neurooncology

  2005cited by this paper
• Pinning down phosphorylated tau and tauopathies.

  2005cited by this paper
• Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.

  2005cited by this paper
• NAAG peptidase inhibitors and their potential for diagnosis and therapy

  2005cited by this paper
• Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging.

  2005cited by this paper
• Positron emission tomography after fetal transplantation in Huntington's disease

  2005cited by this paper
• Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.

  2005cited by this paper
• Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma

  2005cited by this paper
• Neuroimaging and therapeutics in movement disorders

  2005cited by this paper
• 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

  2005cited by this paper
• Positron emission tomography and single-photon emission computed tomography in central nervous system drug development

  2005cited by this paper
• In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis.

  2005cited by this paper
• Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .

  2005cited by this paper
• 201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis

  2004cited by this paper
• The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’?

  2004cited by this paper
• Nanotechnology and tumor imaging: seizing an opportunity.

  2004cited by this paper
• Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease

  2004cited by this paper
• Radiolabeled compounds in diagnosis of infectious and inflammatory disease.

  2004cited by this paper
• Molecular imaging of gene therapy for cancer

  2004cited by this paper
• The GABA-glutamate connection in schizophrenia: which is the proximate cause?

  2004cited by this paper
• Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine

  2004cited by this paper
• Monitoring cell therapy using iron oxide MR contrast agents.

  2004cited by this paper
• Quantification in positron emission tomography for research in pharmacology and drug development.

  2004cited by this paper
• Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

  2004cited by this paper
• Iron oxide MR contrast agents for molecular and cellular imaging

  2004cited by this paper
• Clinical MR neuroimaging : diffusion, perfusion, and spectroscopy

  2004cited by this paper
• Stages in the development of Parkinson’s disease-related pathology

  2004cited by this paper
• Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide.

  2004cited by this paper
• 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.

  2004cited by this paper
• Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery —In malignant glioma—

  2004cited by this paper
• Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis

  2004cited by this paper
• Decreased brain dopaminergic transporters in HIV-associated dementia patients.

  2004cited by this paper
• Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.

  2004cited by this paper
• Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

  2004cited by this paper
• Cerebrovascular perfusion in marijuana users during a month of monitored abstinence

  2004cited by this paper
• Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.

  2004cited by this paper
• Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS

  2004cited by this paper
• A Cyp1a2-luciferase transgenic CD-1 mouse model: responses to aryl hydrocarbons similar to the humanized AhR mice.

  2004cited by this paper
• Hyperpolarized xenon in NMR and MRI.

  2004cited by this paper
• Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

  2004cited by this paper
• Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy

  2004cited by this paper
• Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods.

  2004cited by this paper
• Amyloid beta-peptide: the inside story.

  2004cited by this paper
• Uptake of 6‐[18F]fluoro‐L‐dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease

  2004cited by this paper
• 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET

  2004cited by this paper
• Neuroimaging in leukodystrophies.

  2004cited by this paper
• PET and brain tumor image fusion.

  2004cited by this paper
• Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.

  2004cited by this paper

• Advances in multi-target fluorescent probes for imaging and analyzing biomarkers in Alzheimer’s disease

  2024cites this paper
• Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies.

  2023cites this paper
• PET Imaging of the Neuropeptide Y System: A Systematic Review

  2022cites this paper
• Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.

  2022cites this paper
• The Regulatory Process for Imaging Agents and Devices

  2021cites this paper
• Ultrasound Technologies for Imaging and Modulating Neural Activity.

  2020cites this paper
• A Novel Dual Fluorochrome Near-Infrared Imaging Probe for Potential Alzheimer’s Enzyme Biomarkers-BACE1 and Cathepsin D

  2020cites this paper
• Photoacoustic Imaging of Skin

  2019cites this paper
• Infectious Disease Imaging

  2019cites this paper
• Radiology in Global Health

  2019cites this paper
• Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.

  2017cites this paper
• Molecular Ultrasound Imaging for the Detection of Neural Inflammation: A Longitudinal Dosing Pilot Study

  2017cites this paper
• Targeted Contrast-Enhanced Ultrasound for Inflammation Detection

  2017cites this paper
• Neurologische und dementielle Erkrankungen

  2016cites this paper
• In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.

  2015cites this paper
• University of Groningen Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging Leemans,

  2015cites this paper
• Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging

  2015cites this paper
• Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer's Disease Studies

  2015cites this paper
• Positron Emission Tomography Imaging of Dopaminergic Receptors in Rats

  2015cites this paper
• Opportunities and Challenges: Stem Cell‐Based Therapy for the Treatment of Ischemic Stroke

  2015cites this paper
• Neuroimaging of Parkinson's disease: Expanding views.

  2015cites this paper
• Infectious Disease Imaging

  2014cites this paper
• Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond

  2014cites this paper
• Nanotechnology for Neural Tissue Engineering

  2014cites this paper
• Imaging of Dopamine and Serotonin Receptors and Transporters

  2014cites this paper
• MR-based molecular imaging of the brain : the next frontier Chapter 7

  2014cites this paper
• Prospective interest of molecular neuroimaging in Alzheimer's disease.

  2013cites this paper
• Magnetic resonance microscopy.

  2013cites this paper
• Multimodality Molecular Imaging of Stem Cells Therapy for Stroke

  2013cites this paper
• FDG-PET imaging in HIV infection and tuberculosis.

  2013cites this paper
• Positron emission tomography agents

  2013cites this paper
• Principles of modern neuroimaging

  2012cites this paper
• Tracking stem cells for cellular therapy in stroke.

  2012cites this paper
• Neuroreceptor Imaging

  2012cites this paper
• A molecular imaging primer: modalities, imaging agents, and applications.

  2012cites this paper
• Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use.

  2012cites this paper
• Magnetic Resonance Imaging Contrast Agents

  2012cites this paper
• Biomedical Applications of Emission Tomography

  2012cites this paper
• Modern Trends in Imaging VII: Magnetic Resonance Microscopy

  2011cites this paper
• Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus

  2011cites this paper
• New and emerging imaging techniques for mapping brain circuitry.

  2011cites this paper
• Currently Available Neuroimaging Approaches in Alzheimer Disease (AD) Early Diagnosis

  2011cites this paper
• MRI probes for sensing biologically relevant metal ions.

  2010cites this paper
• PET and SPECT in Drug Development

  2010cites this paper
• Tumeurs hémisphériques intracrâniennes (approche nosologique et sémiologique en imagerie)

  2010cites this paper
• Structure-Function-Based Quantitative Brain Image Analysis.

  2010cites this paper
• In vivo neural stem cell imaging: current modalities and future directions.

  2010cites this paper
• Utilidad del [99m] Tc TRODAT-1 en el diagnóstico de la enfermedad de Parkinson

  2010cites this paper
• Molecular Imaging: The New Frontier in Neurotoxicology

  2010cites this paper
• Smart MR Imaging Agents Relevant to Potential Neurologic Applications

  2010cites this paper
• MR−Based Molecular Imaging of the Brain: The Next Frontier

  2010cites this paper
• Integrative Processes: Neuroscience Clinical Imaging Biomarkers

  2010cites this paper
• The role of positron emission tomography imaging of &bgr;-amyloid in patients with Alzheimer's disease

  2010cites this paper
• Diagnosis and treatment of neuropsychiatric disorders.

  2010cites this paper
• Towards highly efficient, intelligent and bimodal imaging probes: Novel approaches provided by lanthanide coordination chemistry

  2010cites this paper
• Brain and Disease: The Long Path to Discovery and Treatment

  2009cites this paper
• Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

  2009cites this paper
• Review Gera , Steinberg & Guzman

  2009cites this paper
• Small molecule inhibitors in children with malignant gliomas

  2009cites this paper
• Hybrid FMT-CT imaging of amyloid-β plaques in a murine Alzheimer's disease model

  2009cites this paper
• Carborane-carbohydrate derivatives : Versatile platforms for developing targeted radiopharmaceuticals

  2008cites this paper
• 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

  2008cites this paper
• II-35 TAU PROTEIN AND HUMAN TAUOPATHIES : AN OVERWIEV * PROTEIN TAU IN HUMANE TAUPATIJE : PREGLED PODROČJA

  2008cites this paper
• The Role of Molecular Imaging in Drug Discovery and Development

  2008cites this paper
• Fundamentals of molecular imaging: rationale and applications with relevance for radiation oncology.

  2008cites this paper
• Current awareness in contrast media and molecular imaging.

  2008cites this paper
• In Vivo mouse imaging and spectroscopy in drug discovery

  2007cites this paper